![Jeffrey Silber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 579 662 $ al 31/07/2026
Jeffrey Silber currently works at Ironwood Pharmaceuticals, Inc., as Head-Research & Drug Development from 2026.
Dr. Silber also formerly worked at Vedanta Biosciences, Inc., as Chief Medical Officer from 2020 to 2026.
Dr. Silber received his undergraduate degree from Harvard University and doctorate degree from Albert Einstein College of Medicine, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/07/2026 | 137.036 ( 0,08 % ) | 579 662 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 20/07/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Director Técnico/Científico/I+D | 01/07/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
